Robot-assisted nephroureterectomy

IF 2.3 3区医学 Q3 ONCOLOGY

Urologic Oncology-seminars and Original Investigations Pub Date : 2025-07-03 DOI:10.1016/j.urolonc.2025.06.002

Mohit Butaney , Michael Wang , Craig G. Rogers , Johar Raza

引用次数: 0

Abstract

Nephroureterectomy is the standard of care for high grade and recurrent low grade upper urinary tract urothelial cell carcinoma (UTUC). Robot-assisted nephroureterectomy (RANU) is an established technique for the minimally invasive performance of nephroureterectomy and has grown to be the favored approach over the past decade. The 3-dimensional vision, efficient wristed suturing, and precise movements of RANU offer advantages over laparoscopic nephroureterectomy (LNU). In addition to the expected benefits with reduced perioperative morbidity, available oncological outcomes are comparable to data associated with other published series. In this review we discuss the indications, preparation, technique, and oncologic outcomes of transperitoneal RANU.

查看原文本刊更多论文

机器人援助nephroureterectomy。

肾输尿管切除术是高级别和复发性低级别上尿路尿路上皮细胞癌（UTUC）的标准治疗方法。机器人辅助肾输尿管切除术（RANU）是一种微创肾输尿管切除术的成熟技术，在过去的十年中已经成为一种受欢迎的方法。RANU的三维视觉，高效的手腕缝合和精确的运动提供了腹腔镜肾输尿管切除术（LNU）的优势。除了预期的减少围手术期发病率的益处外，现有的肿瘤预后与其他已发表的系列研究数据相当。在这篇综述中，我们讨论了适应症，制备，技术和经腹腔RANU的肿瘤学结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Urologic Oncology-seminars and Original Investigations 医学-泌尿学与肾脏学

CiteScore

4.80

自引率

3.70%

发文量

297

审稿时长

7.6 weeks

期刊介绍： Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.